Sutro Biopharma, Inc. (STRO)
15.34
-0.14
(-0.90%)
USD |
NASDAQ |
Sep 18, 16:00
15.32
-0.02
(-0.13%)
After-Hours: 20:00
Sutro Biopharma Market Cap : 254.28M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 254.28M |
| September 17, 2026 | 256.60M |
| September 16, 2026 | 258.59M |
| September 15, 2026 | 274.50M |
| September 14, 2026 | 280.30M |
| September 11, 2026 | 279.47M |
| September 10, 2026 | 295.55M |
| September 09, 2026 | 304.26M |
| September 08, 2026 | 316.61M |
| September 04, 2026 | 332.68M |
| September 03, 2026 | 340.48M |
| September 02, 2026 | 339.31M |
| September 01, 2026 | 345.12M |
| August 31, 2026 | 335.50M |
| August 28, 2026 | 338.98M |
| August 27, 2026 | 353.24M |
| August 26, 2026 | 355.23M |
| August 25, 2026 | 355.39M |
| August 24, 2026 | 339.65M |
| August 21, 2026 | 348.76M |
| August 20, 2026 | 350.75M |
| August 19, 2026 | 363.18M |
| August 18, 2026 | 365.34M |
| August 17, 2026 | 369.32M |
| August 14, 2026 | 339.48M |
| Date | Value |
|---|---|
| August 13, 2026 | 353.24M |
| August 12, 2026 | 353.07M |
| August 11, 2026 | 415.07M |
| August 10, 2026 | 423.19M |
| August 07, 2026 | 420.70M |
| August 06, 2026 | 400.09M |
| August 05, 2026 | 415.83M |
| August 04, 2026 | 425.27M |
| August 03, 2026 | 415.83M |
| July 31, 2026 | 400.42M |
| July 30, 2026 | 411.19M |
| July 29, 2026 | 386.34M |
| July 28, 2026 | 393.13M |
| July 27, 2026 | 397.77M |
| July 24, 2026 | 379.05M |
| July 23, 2026 | 390.98M |
| July 22, 2026 | 387.66M |
| July 21, 2026 | 381.04M |
| July 20, 2026 | 374.24M |
| July 17, 2026 | 390.48M |
| July 16, 2026 | 393.13M |
| July 15, 2026 | 430.74M |
| July 14, 2026 | 431.23M |
| July 13, 2026 | 461.22M |
| July 10, 2026 | 492.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Upstream Bio, Inc. | 292.48M |
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
Market Cap Related Metrics
| PS Ratio | 3.921 |
| PEG Ratio | -0.0178 |
| Price | 15.34 |
| Earnings Yield | -113.5% |
| PEGY Ratio | -0.0178 |